| |
| |
|
| Insider
Information: |
Green Eric Mark |
| Relationship: |
|
| City: |
Chesterfield |
| State: |
MO |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
188,586 |
|
|
Indirect Shares
|
2,819 |
|
|
| Direct
Value |
$57,981,454 |
|
|
|
Indirect Value
|
$88,199 |
|
|
| Total
Shares |
191,405 |
|
|
| Total
Value |
$58,069,653 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sigma-Aldrich Corp |
SIAL |
EVP & President, Resea... |
2015-03-12 |
24,964 |
2015-03-12 |
2,571 |
Premium* |
|
|
West Pharmaceutical Services Inc |
WST |
President, CEO and Boa... |
2024-05-07 |
161,908 |
2017-02-14 |
248 |
Premium* |
|
|
Ecolab Inc |
ECL |
|
2024-03-31 |
1,714 |
2022-12-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| WST |
West Pharmaceutical Servi... |
President & CEO |
• • – |
2022-02-13 |
4 |
D |
$391.20 |
$33,252 |
D/D |
(85) |
86,818 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
President & CEO |
• • – |
2023-08-08 |
4 |
AS |
$389.62 |
$17,369,820 |
D/D |
(44,000) |
140,574 |
0 |
% |
|
| WST |
West Pharmaceutical Servi... |
President & CEO |
• • – |
2022-02-22 |
4 |
A |
$369.13 |
$8,159,250 |
D/D |
22,104 |
108,922 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
President, CEO and Board Chair |
• • – |
2024-05-07 |
4 |
AS |
$366.64 |
$24,199,050 |
D/D |
(66,000) |
152,908 |
0 |
% |
|
| WST |
West Pharmaceutical Servi... |
President & CEO |
• • – |
2023-05-09 |
4 |
AS |
$361.95 |
$15,976,522 |
D/D |
(44,000) |
134,574 |
0 |
% |
|
| WST |
West Pharmaceutical Servi... |
President, CEO and Board Chair |
• • – |
2024-02-27 |
4 |
AS |
$359.85 |
$23,077,971 |
D/D |
(64,132) |
152,908 |
0 |
% |
|
| WST |
West Pharmaceutical Servi... |
President, CEO and Board Chair |
• • – |
2023-12-06 |
4 |
GD |
$343.00 |
$3,361,400 |
D/D |
9,800 |
130,774 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
President & CEO |
• • – |
2023-03-07 |
4 |
AS |
$320.60 |
$14,183,531 |
D/D |
(44,000) |
128,574 |
0 |
% |
|
| WST |
West Pharmaceutical Servi... |
President & CEO |
• • – |
2023-02-21 |
4 |
A |
$306.68 |
$4,533,650 |
D/D |
14,783 |
129,705 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
President & CEO |
• • – |
2021-02-14 |
4 |
D |
$294.01 |
$27,049 |
D/D |
(92) |
72,286 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
President & CEO |
• • – |
2021-02-22 |
4 |
A |
$272.65 |
$4,844,173 |
D/D |
17,767 |
90,053 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
President & CEO |
• • – |
2022-12-05 |
4 |
AS |
$236.95 |
$10,515,518 |
D/D |
(44,000) |
114,922 |
0 |
% |
|
| WST |
West Pharmaceutical Servi... |
President & CEO |
• • – |
2020-06-03 |
4 |
D |
$197.94 |
$990 |
D/D |
(5) |
72,378 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
President & CEO |
• • – |
2020-04-24 |
4 |
D |
$195.54 |
$1,145,473 |
D/D |
(5,858) |
72,373 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
President & CEO |
• • – |
2020-02-18 |
4 |
A |
$173.22 |
$1,626,882 |
D/D |
9,392 |
78,423 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
President & CEO |
• • – |
2020-02-23 |
4 |
D |
$170.16 |
$32,671 |
D/D |
(192) |
78,231 |
0 |
- |
|
| SIAL |
Sigma-Aldrich Corp |
EVP & President, Research |
• – – |
2015-03-12 |
4 |
S |
$138.20 |
$4,251,032 |
D/D |
(30,760) |
24,964 |
0 |
- |
|
| SIAL |
Sigma-Aldrich Corp |
EVP & President, Research |
• – – |
2015-03-09 |
4 |
D |
$138.07 |
$85,741 |
D/D |
(621) |
10,008 |
0 |
- |
|
| SIAL |
Sigma-Aldrich Corp |
EVP & President, Research |
• – – |
2014-12-18 |
4 |
OE |
$136.35 |
$2,167,909 |
D/D |
15,900 |
8,768 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
President & CEO |
• • – |
2019-02-19 |
4 |
A |
$102.51 |
$618,545 |
D/D |
6,034 |
69,031 |
0 |
- |
|
| SIAL |
Sigma-Aldrich Corp |
EVP & President, Research |
• – – |
2014-08-08 |
4 |
D |
$101.93 |
$68,089 |
D/D |
(668) |
8,768 |
0 |
- |
|
| SIAL |
Sigma-Aldrich Corp |
EVP & President, Research |
• – – |
2014-05-29 |
4 |
S |
$98.03 |
$445,444 |
D/D |
(4,544) |
7,436 |
0 |
- |
|
| SIAL |
Sigma-Aldrich Corp |
EVP & President, Research |
• – – |
2014-02-10 |
4 |
D |
$93.07 |
$57,610 |
D/D |
(619) |
6,080 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
President & CEO |
• • – |
2018-02-13 |
4 |
A |
$93.00 |
$1,046,901 |
D/D |
11,257 |
70,713 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
President & CEO |
• • – |
2018-04-24 |
4 |
D |
$92.00 |
$709,872 |
D/D |
(7,716) |
62,997 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
